Mercedes Heras

Mercedes Heras

Auto-generated profile, based on publicly available information

Mercedes Heras

Vascular Medicine and Metabolism Unit, Research Unit on Lipids and Atherosclerosis, Sant Joan University Hospital, Universitat Rovira i Virgili, IISPV, 43201 Reus, Spain

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
RMRoger Mallol
Roger Mallol
NANúria Amigó
Núria Amigó
MRMiguel Ángel Rodríguez-Gómez
Miguel Ángel Rodríguez-Gómez
MHMercedes Heras
Mercedes Heras
MVMaria Vinaixa
Maria Vinaixa
XCXavier Correig
Xavier Correig
Determination of lipoprotein particle size and number using advanced lipoprotein tests (ALTs) is of particular importance to improve cardiovascular risk prediction. Here we present the Liposcale test, a novel ALT based on 2D diffusion-ordered 1H NMR spectroscopy. Our method uses diffusion coefficients to provide a direct measure of the mean particle sizes and numbers. Using 177 plasma samples from healthy individuals and the concentration of apolipoprotein B and A from isolated lipoprotein fractions our test showed a stronger correlation between the NMR-derived lipoprotein particle numbers and apolipoprotein concentrations than the LipoProfile® test commercialized by Liposcience. We also converted LDL particle numbers to ApoB equivalents (mg/dL) and our test yielded similar values of LDL-ApoB than the LipoProfile® test (absolute mean bias of 8.5 and 7.4 mg/dL, respectively). In addition, our HDL-P values were more concordant with the calibrated values determined recently using ion mobility. Finally, principal component analysis distinguished type 2 diabetic patients with and without atherogenic dyslipidemia (AD) on a second cohort of 307 subjects characterized using the Liposcale test (AUC=0.88) and showed concordant relationships between variables explaining AD. Altogether, our method provides reproducible and reliable characterization of lipoprotein particles and it is applicable to pathological states such as AD.

Verified
Journal Article
Open access
PDF file
JGJosefa Girona-Tell
Josefa Girona-Tell
NANúria Amigó
Núria Amigó
DIDaiana Ibarretxe
Daiana Ibarretxe
NPNúria Plana
Núria Plana
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
LMLluís Masana
Lluís Masana
While cholesterol content in high-density lipoproteins (HDLs) is a well-established inverse marker of cardiovascular risk, the importance of HDL–triglyceride (HDL-TG) concentration is not well known. We aim to examine plasma HDL-TG concentrations, assessed by 1H-NMR, in patients with metabolic diseases and their association with classical biomarkers. In this cross-sectional study, we included 502 patients with type 2 diabetes or metabolic syndrome attending the lipid unit of our University Hospital. The presence of arteriosclerotic plaques was assessed by ultrasonography. A complete lipoprotein profile was performed by 1H-NMR (Liposcale test). HDL-TG was strongly positively correlated with total triglycerides, glycerol, and fatty liver index, while a strong negative correlation was observed with HDL-cholesterol (HDL-C) and HDL-particle number (HDL-P). HDL-TG was associated with all triglyceride-rich lipoprotein parameters and had an opposite association with HDL-C and HDL-P. It was also significantly correlated with circulating cholesterol ester transfer protein (CETP). HDL-TG concentrations were higher as metabolic syndrome components increased. HDL-TG was also higher with worsening glucose metabolism. Patients with carotid plaques also showed higher HDL-TG. In contrast to HDL-C, HDL-TG is directly associated with metabolism and arteriosclerotic vascular alterations. HDL-TG should be considered a biomarker of metabolic and cardiovascular risk and could be a marker of HDL dysfunction.

18 June 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
GAGemma Aragonès
Gemma Aragonès
PSPaula Saavedra
Paula Saavedra
MHMercedes Heras
Mercedes Heras
ACAnna Cabré
Anna Cabré
JGJosefa Girona-Tell
Josefa Girona-Tell
LMLluís Masana
Lluís Masana
Background: Recent studies have shown that fatty acid-binding protein 4 (FABP4) plasma levels are associated with impaired endothelial function in type 2 diabetes (T2D). In this work, we analysed the effect of FABP4 on the insulin-mediated nitric oxide (NO) production by endothelial cells in vitro. Methods: In human umbilical vascular endothelial cells (HUVECs), we measured the effects of FABP4 on the insulin-mediated endothelial nitric oxide synthase (eNOS) expression and activation and on NO production. We also explored the impact of exogenous FABP4 on the insulin-signalling pathway (insulin receptor substrate 1 (IRS1) and Akt). Results: We found that eNOS expression and activation and NO production are significantly inhibited by exogenous FABP4 in HUVECs. FABP4 induced an alteration of the insulin-mediated eNOS pathway by inhibiting IRS1 and Akt activation. These results suggest that FABP4 induces endothelial dysfunction by inhibiting the activation of the insulin-signalling pathway resulting in decreased eNOS activation and NO production. Conclusion: These findings provide a mechanistic linkage between FABP4 and impaired endothelial function in diabetes, which leads to an increased cardiovascular risk.

17 January 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
RBRubén Barrilero
Rubén Barrilero
MGMiriam Gil
Miriam Gil
NANúria Amigó
Núria Amigó
Cintia Botelho DiasCintia Botelho Dias
Cintia Botelho Dias
LWLisa G. Wood
Lisa G. Wood
XCXavier Correig
Xavier Correig

26 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JGJosefa Girona-Tell
Josefa Girona-Tell
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
DIDaiana Ibarretxe
Daiana Ibarretxe
JVJoan-Carles Vallvé
Joan-Carles Vallvé
RFRaimon Ferré
Raimon Ferré
LMLluís Masana
Lluís Masana
Background: Glucose-regulated protein 78/Binding immunoglobulin protein (GRP78/BiP) is a protein associated with endoplasmic reticulum stress and is upregulated by metabolic alterations at the tissue-level, such as hypoxia or glucose deprivation, and it is hyper-expressed in fat tissue of obese individuals. Objective: To investigate the role of the GRP78/BiP level as a metabolic and vascular disease biomarker in patients with type 2 diabetes (DM), obesity and metabolic syndrome (MS). Methods: Four hundred and five patients were recruited, of whom 52.5% were obese, 72.8% had DM, and 78.6% had MS. The intimae media thickness (cIMT) was assessed by ultrasonography. The plasma GRP78/BiP concentration was determined, and its association with metabolic and vascular parameters was assessed. Circulating GRP78/BiP was also prospectively measured in 30 DM patients before and after fenofibrate/niacin treatment and 30 healthy controls. Results: In the cross-sectional study, the GRP78/BiP level was significantly higher in the patients with obesity, DM, and MS. Age-, gender- and BMI-adjusted GRP78/BiP was directly associated with LDL-cholesterol, non-HDL-cholesterol, triglycerides, apoB, and cIMT. GRP78/BiP was positively associated to carotid plaque presence in the adjusted model, irrespective of obesity, DM and MS. In the prospective study, nicotinic acid treatment produced a significant reduction in the GRP78/BiP levels that was not observed with fenofibrate. Conclusions: GRP78/BiP plasma concentrations are increased in patients with both metabolic derangements and subclinical atherosclerosis. GRP78/BiP could be a useful marker of metabolic and cardiovascular risk.

1 March 2018 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
LMLluís Masana
Lluís Masana
JGJosefa Girona-Tell
Josefa Girona-Tell
DIDaiana Ibarretxe
Daiana Ibarretxe
RRRicardo Rodríguez-Calvo
Ricardo Rodríguez-Calvo
RRRoser Rosales
Roser Rosales
NPNúria Plana
Núria Plana